Portfolio news 0

Artios Pharma

Artios Pharma Appoints Michael T. Andriole as CEO and Director to Advance Alnodesertib (ART0380) into Late-stage Development

First Light Fusion Ltd

First Light Fusion Sets World Record for Pressure on Its Two-Stage Gas Gun

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies Plc - Chief Executive Officer Succession

Oxford Nanopore Technologies Plc

ViruSure launches pioneering viral contamination test for biopharmaceuticals using Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies Plc

Commencement of legal action against MGI Australia

Hinge Health, Inc.

Hinge Health Reports Second Quarter 2025 Financial Results

Oxa

NEAA and Consortium Launch Groundbreaking Autonomous Logistics Project at the Port of Tyne

Monolith

Monolith and CamMotive Join Forces To Drive Faster, More Accurate EV Battery Testing with AI

Slamcore

Slamcore and Locaxion Announce Strategic Partnership Combining Spatial Intelligence and Location Intelligence to Revolutionize Industrial Operations

Microbiotica Ltd

Microbiotica Announces Completion of Recruitment in its Phase 1b Trial (COMPOSER-1) of MB310, a Precision Microbiome Medicine, in Ulcerative Colitis Patients